Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma

Clinical trial NCT06613841 · RECRUITING

Trial details

NCT number: NCT06613841
Sponsor: Abramson Cancer Center at Penn Medicine
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Glioblastoma Recurrent Glioblastoma Glioblastoma Multiforme of Brain

Start date: 2025-05-01
Primary completion: 2026-10-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.